CLINICAL_TRIALS
trial_result
· 2021-05-18
Clinical Trial Update: GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1) [Phase 1]
Summary
Phase 1 trial updates for GSK3174998 alone and with pembrolizumab in advanced solid tumors (ENGAGE-1) completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2021-05-18